Alzheimer disease and Down syndrome: factors in pathogenesis
about
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndromeAccelerated epigenetic aging in Down syndromeIntracerebral haemorrhage in Down syndrome: protected or predisposed?At the interface of sensory and motor dysfunctions and Alzheimer's disease.Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of Down syndromeDrugs for Alzheimer's diseaseBrain plasticity and disease: a matter of inhibition.Inositol Pyrophosphate Kinase Asp1 Modulates Chromosome Segregation Fidelity and Spindle Function in Schizosaccharomyces pombe.Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon.Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration.Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.Sos7, an essential component of the conserved Schizosaccharomyces pombe Ndc80-MIND-Spc7 complex, identifies a new family of fungal kinetochore proteinsIs Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?Identification of a DNA methylation signature in blood cells from persons with Down Syndrome.Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.Amyloid-β(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus.Age-related neurodegeneration and memory loss in down syndrome.Antioxidants in Down syndrome.Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APPImaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.Altered expression of KIF17, a kinesin motor protein associated with NR2B trafficking, may mediate learning deficits in a Down syndrome mouse model.The cognitive phenotype of Down syndrome: insights from intracellular network analysisNatural products as a rich source of tau-targeting drugs for Alzheimer's disease.Adaptive downregulation of mitochondrial function in down syndromeHypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis.Mutation-based structural modification and dynamics study of amyloid beta peptide (1-42): An in-silico-based analysis to cognize the mechanism of aggregation.The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease.Anti-amyloid-beta immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials.Amyloid-β induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse.Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegenerationCognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathwayNurturing brain plasticity: impact of environmental enrichment.Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatmentsγ-Secretase-regulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease.Atypical aging in Down syndrome.The role of apolipoprotein E in neurodegeneration and cardiovascular disease.GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms.Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age
P2860
Q21136371-CA9248F3-89D1-433D-A3A7-9DCC9CD0877CQ22242648-D5BF679E-F218-4CEE-A931-F2AEEA9FD54BQ26745369-D8455B4F-343D-4055-B807-B1F04F53BB68Q27000410-0A35A784-8EDF-4608-AB8D-BAB8F247890AQ27303804-1C6B579F-2A09-49F6-A18D-7C77E7F0095AQ28728362-569F75E5-EDCE-4E85-8054-C318D107F1D5Q30474810-CDA6DB02-D982-4F6F-864B-B1A8E648FF61Q30830013-AD247507-A0EA-44F6-8202-C334B104B20AQ33289262-5D908465-8328-4A70-B74A-2F2B19E2C63CQ34048835-B4E92CCE-9806-4C59-8A3C-CB3BD8D19DEBQ34246990-6FC1C45C-7DD9-469C-B6C4-99906BB625D6Q34308636-0530D767-9B49-4BE7-A02D-700D39DA58E1Q34917679-81AA910C-C585-4B78-AC21-F3C6095F1D0DQ35177595-02FA3F32-3F32-4F4F-9DD8-3D76B7EF3898Q35677159-C6CFCB6C-59C5-4A40-A520-7B5B3F4F2290Q35719617-86962DC4-FE4E-42AE-A0EB-3645CE01293DQ35867093-01CE29D5-36AA-4A54-86FC-9A70D131BAEFQ36126681-17423FEE-2B3F-4AE5-9538-79D0A1C370D0Q36332872-3A500DEC-8FDB-421B-8F8D-039017C7EE96Q36495294-F7F22EF7-D355-42C4-8382-3AD3AFEC2760Q36508541-D34E1E3E-C56E-4CEF-8D60-32D7313C36A7Q36525183-C2046FEF-B8E4-4CA4-B537-3417613AD2D3Q36617889-FD394BE2-D54C-4444-9560-FF389CECA68AQ36632280-9B018C25-1A54-432F-828E-A9448F6A76D0Q36637693-D62E0680-BCEC-4A5C-8676-D65C8D8C17BDQ36652734-C4DB6854-826A-46BD-ADE6-3E895BD1F6ACQ36784902-6C3BEBDB-CED5-458A-8D38-021B47DACEB8Q37041524-EDDC4186-7DBA-4D34-AB77-56683D07DB7BQ37043451-0C7271A8-4013-4C04-9D7B-7A0343B4D75CQ37270004-1198E527-3512-45DE-BCB0-005A1AD1AEF7Q37279515-6B821931-5EC8-4185-AC82-2C7FAF48CC62Q37415858-270B526F-C0E1-4037-BD25-7EF043523847Q37658290-B27A5E44-D742-4580-AD42-A448A7F6B62FQ37730984-15C326C8-F2F4-4BBC-A918-56A23BA5C29FQ37868452-0563708B-BEF2-4C3D-B98C-A93FC5674C4FQ38129325-55E7D900-4F4E-452A-B833-B092FCEA8A70Q38206263-844ADEAB-C99D-4F58-AD4E-CF4C42C56186Q38225536-5AA7D10A-16CF-46FF-9051-05B15182A83AQ38245648-DD424AF1-6D5B-4D93-AFD5-EE44383802ECQ38793564-8A9B07BF-CCEA-4FA6-98EF-3073D47BF0E8
P2860
Alzheimer disease and Down syndrome: factors in pathogenesis
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Alzheimer disease and Down syndrome: factors in pathogenesis
@ast
Alzheimer disease and Down syndrome: factors in pathogenesis
@en
Alzheimer disease and Down syndrome: factors in pathogenesis
@en-gb
Alzheimer disease and Down syndrome: factors in pathogenesis
@nl
type
label
Alzheimer disease and Down syndrome: factors in pathogenesis
@ast
Alzheimer disease and Down syndrome: factors in pathogenesis
@en
Alzheimer disease and Down syndrome: factors in pathogenesis
@en-gb
Alzheimer disease and Down syndrome: factors in pathogenesis
@nl
prefLabel
Alzheimer disease and Down syndrome: factors in pathogenesis
@ast
Alzheimer disease and Down syndrome: factors in pathogenesis
@en
Alzheimer disease and Down syndrome: factors in pathogenesis
@en-gb
Alzheimer disease and Down syndrome: factors in pathogenesis
@nl
P3181
P1476
Alzheimer disease and Down syndrome: factors in pathogenesis
@en
P2093
Elizabeth Head
Ira T. Lott
P304
P3181
P356
10.1016/J.NEUROBIOLAGING.2004.08.005
P407
P577
2005-03-01T00:00:00Z